Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 565

1.

Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.

Bitting RL, Healy P, George DJ, Anand M, Kim S, Mayer T, Winters C, Riggan C, Rasmussen J, Wilder R, Stein M, Frizzell B, Harrison MR, Zhang T, Lee WR, Wu Y, Koontz BF, Armstrong AJ.

Eur Urol Oncol. 2020 Feb 13. pii: S2588-9311(20)30020-1. doi: 10.1016/j.euo.2020.01.005. [Epub ahead of print]

PMID:
32063492
2.

Clinical Decision Supports in Electronic Health Records to Promote Childhood Obesity-Related Care: Results from a 2015 Survey of Healthcare Providers.

Harrison MR, Lundeen EA, Belay B, Goodman AB.

Clin Nutr Res. 2019 Oct 14;8(4):255-264. doi: 10.7762/cnr.2019.8.4.255. eCollection 2019 Oct.

3.

Late developing cardiac lymphatic vasculature supports adult zebrafish heart function and regeneration.

Harrison MR, Feng X, Mo G, Aguayo A, Villafuerte J, Yoshida T, Pearson CA, Schulte-Merker S, Lien CL.

Elife. 2019 Nov 8;8. pii: e42762. doi: 10.7554/eLife.42762.

4.

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.

Motzer RJ, Jonasch E, Michaelson MD, Nandagopal L, Gore JL, George S, Alva A, Haas N, Harrison MR, Plimack ER, Sosman J, Agarwal N, Bhayani S, Choueiri TK, Costello BA, Derweesh IH, Gallagher TH, Hancock SL, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Lewis B, Manley B, McCreery B, McDonald A, Mortazavi A, Pierorazio PM, Ponsky L, Redman BG, Somer B, Wile G, Dwyer MA; CGC, Hammond LJ, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Nov 1;17(11):1278-1285. doi: 10.6004/jnccn.2019.0054.

PMID:
31693980
5.

Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer.

George DJ, Halabi S, Healy P, Barak I, Winters C, Anand M, Wilder R, Klein M, Martinez E, Nixon AB, Harrison MR, Szmulewitz R, Armstrong AJ.

Prostate. 2019 Nov;79(15):1752-1761. doi: 10.1002/pros.23899. Epub 2019 Sep 9.

PMID:
31497882
6.

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.

Motzer RJ, Rini BI, McDermott DF, Arén Frontera O, Hammers HJ, Carducci MA, Salman P, Escudier B, Beuselinck B, Amin A, Porta C, George S, Neiman V, Bracarda S, Tykodi SS, Barthélémy P, Leibowitz-Amit R, Plimack ER, Oosting SF, Redman B, Melichar B, Powles T, Nathan P, Oudard S, Pook D, Choueiri TK, Donskov F, Grimm MO, Gurney H, Heng DYC, Kollmannsberger CK, Harrison MR, Tomita Y, Duran I, Grünwald V, McHenry MB, Mekan S, Tannir NM; CheckMate 214 investigators.

Lancet Oncol. 2019 Oct;20(10):1370-1385. doi: 10.1016/S1470-2045(19)30413-9. Epub 2019 Aug 16. Erratum in: Lancet Oncol. 2019 Aug 21;:.

PMID:
31427204
7.

Presidential Forum.

Ellison EC, Ponsky JL, Harrison MR, McGrath MH, Angelos P, Krummel TM.

Ann Surg. 2019 Oct;270(4):573-584. doi: 10.1097/SLA.0000000000003421. No abstract available.

PMID:
31274654
8.

An experimental study on magnetic esophageal compression anastomosis in piglets.

Muensterer OJ, Sterlin A, Oetzmann von Sochaczewski C, Lindner A, Heimann A, Balus A, Dickmann J, Nuber M, Patel VH, Manfredi MA, Jennings RW, Smithers CJ, Fauza DO, Harrison MR.

J Pediatr Surg. 2020 Mar;55(3):425-432. doi: 10.1016/j.jpedsurg.2019.04.029. Epub 2019 May 11.

PMID:
31128845
9.

Endoscopic Magnetic Compression Anastomosis For Small Bowel Bypass in a High Operative Risk Setting.

Lebares CC, Graves CE, Lin MY, Fidelman N, Cello J, Harrison MR, Rogers S.

Surg Laparosc Endosc Percutan Tech. 2019 Oct;29(5):e84-e87. doi: 10.1097/SLE.0000000000000669.

PMID:
31107851
10.

Biomaterials in fetal surgery.

Winkler SM, Harrison MR, Messersmith PB.

Biomater Sci. 2019 Aug 1;7(8):3092-3109. doi: 10.1039/c9bm00177h. Epub 2019 May 17. Review.

PMID:
31099350
11.

Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer.

Meleis L, Moore R, Inman BA, Harrison MR.

J Oncol Pharm Pract. 2020 Mar;26(2):330-337. doi: 10.1177/1078155219845434. Epub 2019 May 12.

PMID:
31081469
12.

Beyond Magnamosis: A Method to Test Sutureless Esophageal Anastomotic Devices in Living Swine by Creating an Esophageal Bypass Loop for Natural Oral Nutrition.

Oetzmann von Sochaczewski C, Lindner A, Heimann A, Balus A, Patel VH, Harrison MR, Muensterer OJ.

J Laparoendosc Adv Surg Tech A. 2019 Jun;29(6):852-855. doi: 10.1089/lap.2018.0778. Epub 2019 Mar 18.

PMID:
30882275
13.

Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.

Labriola MK, Batich KA, Zhu J, McNamara MA, Harrison MR, Armstrong AJ, George DJ, Zhang T.

Clin Genitourin Cancer. 2019 Jun;17(3):e513-e521. doi: 10.1016/j.clgc.2019.01.017. Epub 2019 Feb 5. Review.

PMID:
30858035
14.

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.

Martínez Chanzá N, Xie W, Asim Bilen M, Dzimitrowicz H, Burkart J, Geynisman DM, Balakrishnan A, Bowman IA, Jain R, Stadler W, Zakharia Y, Narayan V, Beuselinck B, McKay RR, Tripathi A, Pachynski R, Hahn AW, Hsu J, Shah SA, Lam ET, Rose TL, Mega AE, Vogelzang N, Harrison MR, Mortazavi A, Plimack ER, Vaishampayan U, Hammers H, George S, Haas N, Agarwal N, Pal SK, Srinivas S, Carneiro BA, Heng DYC, Bosse D, Choueiri TK, Harshman LC.

Lancet Oncol. 2019 Apr;20(4):581-590. doi: 10.1016/S1470-2045(18)30907-0. Epub 2019 Feb 28.

15.

Screening and Referral for Childhood Obesity: Adherence to the U.S. Preventive Services Task Force Recommendation.

Imoisili OE, Goodman AB, Dooyema CA, Harrison MR, Belay B, Park S.

Am J Prev Med. 2019 Feb;56(2):179-186. doi: 10.1016/j.amepre.2018.10.003. Epub 2018 Dec 17.

PMID:
30573333
16.

Look and You Will Find It: Practical Considerations for Improving Multidisciplinary Management of Androgen-Deprivation Therapy-Induced Cardiometabolic Toxicity.

Khouri MG, Harrison MR.

J Oncol Pract. 2018 Oct;14(10):591-593. doi: 10.1200/JOP.18.00543. No abstract available.

PMID:
30312562
17.

Magnetic compression anastomosis (magnamosis) in a porcine esophagus: Proof of concept for potential application in esophageal atresia.

Bruns NE, Glenn IC, Craner DR, Schomisch SJ, Harrison MR, Ponsky TA.

J Pediatr Surg. 2019 Mar;54(3):429-433. doi: 10.1016/j.jpedsurg.2018.09.014. Epub 2018 Sep 29.

PMID:
30309731
18.

Dietary patterns and health-related quality of life in bladder cancer survivors.

Gopalakrishna A, Chang A, Longo TA, Fantony JJ, Harrison MR, Wischmeyer PE, Inman BA.

Urol Oncol. 2018 Oct;36(10):469.e21-469.e29. doi: 10.1016/j.urolonc.2018.06.001. Epub 2018 Aug 17.

PMID:
30126776
19.

How we treat brain metastases in metastatic renal cell carcinoma.

Ramalingam S, George DJ, Harrison MR.

Clin Adv Hematol Oncol. 2018 Feb;16(2):110-114. Review. No abstract available.

PMID:
29741510
20.

Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy.

Brousell SC, Fantony JJ, Van Noord MG, Harrison MR, Inman BA.

Core Evid. 2018 Jan 24;13:1-12. doi: 10.2147/CE.S118670. eCollection 2018. Review.

21.

Minimally Invasive Fetal Surgery.

Graves CE, Harrison MR, Padilla BE.

Clin Perinatol. 2017 Dec;44(4):729-751. doi: 10.1016/j.clp.2017.08.001. Epub 2017 Sep 23. Review.

PMID:
29127956
22.

Magnetic Compression Anastomosis (Magnamosis): First-In-Human Trial.

Graves CE, Co C, Hsi RS, Kwiat D, Imamura-Ching J, Harrison MR, Stoller ML.

J Am Coll Surg. 2017 Nov;225(5):676-681.e1. doi: 10.1016/j.jamcollsurg.2017.07.1062. Epub 2017 Aug 23.

23.

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH, Gore JL, Hancock SL, Harrison MR, Kim W, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Michaelson MD, Olencki T, Pierorazio PM, Plimack ER, Redman BG, Shuch B, Somer B, Sonpavde G, Sosman J, Dwyer M, Kumar R.

J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.

PMID:
28596261
24.

Physical activity patterns and associations with health-related quality of life in bladder cancer survivors.

Gopalakrishna A, Longo TA, Fantony JJ, Harrison MR, Inman BA.

Urol Oncol. 2017 Sep;35(9):540.e1-540.e6. doi: 10.1016/j.urolonc.2017.04.016. Epub 2017 May 17.

25.

How Can We Effectively Address the Medical and Psychological Concerns of Survivors of Pelvic Malignancies?

Madden-Fuentes RJ, Koontz BF, Harrison MR, George DJ, Davidson B, Gilmore BF, Moul JW, Mantyh C, Peterson AC.

Oncology (Williston Park). 2017 Apr 15;31(4):286-94. Review.

26.

Design and Rationale of the Metastatic Renal Cell Carcinoma (MaRCC) Registry: A Prospective Academic and Community-Based Study of Patients With Metastatic Renal Cell Cancer.

Bhavsar NA, Harrison MR, Hirsch BR, Creel P, Wolf SP, Samsa GP, Abernethy AP, Simantov R, Borham A, George DJ.

Cancer Invest. 2017 May 28;35(5):333-344. doi: 10.1080/07357907.2017.1289215. Epub 2017 Apr 3.

PMID:
28368708
27.

Magnetic Mini-Mover Procedure for pectus excavatum IV: FDA sponsored multicenter trial.

Graves CE, Hirose S, Raff GW, Iqbal CW, Imamura-Ching J, Christensen D, Fechter R, Kwiat D, Harrison MR.

J Pediatr Surg. 2017 Jun;52(6):913-919. doi: 10.1016/j.jpedsurg.2017.03.009. Epub 2017 Mar 15.

PMID:
28342579
28.

Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.

Ramalingam S, Humeniuk MS, Hu R, Rasmussen J, Healy P, Wu Y, Harrison MR, Armstrong AJ, George DJ, Zhang T.

Urol Oncol. 2017 Jun;35(6):418-424. doi: 10.1016/j.urolonc.2016.12.016. Epub 2017 Jan 23.

PMID:
28126272
29.

Structure and Electronic Properties of the Quasi-One-Dimensional Ba2Co1-xZnxS3 Series.

Harrison MR, Maignan A, Hardy V, Lebedev OI, Young NA, Francesconi MG.

Inorg Chem. 2017 Jan 3;56(1):213-223. doi: 10.1021/acs.inorgchem.6b02014. Epub 2016 Dec 16.

PMID:
27983814
30.

Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer.

Inman BA, Longo TA, Ramalingam S, Harrison MR.

Clin Cancer Res. 2017 Apr 15;23(8):1886-1890. doi: 10.1158/1078-0432.CCR-16-1417. Epub 2016 Nov 30. Review.

31.

Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.

Armstrong AJ, Humeniuk MS, Healy P, Szmulewitz R, Winters C, Kephart J, Harrison MR, Martinez E, Mundy K, Halabi S, George D.

Prostate. 2017 Mar;77(4):385-395. doi: 10.1002/pros.23277. Epub 2016 Nov 16.

32.

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.

Choueiri TK, Fishman MN, Escudier B, McDermott DF, Drake CG, Kluger H, Stadler WM, Perez-Gracia JL, McNeel DG, Curti B, Harrison MR, Plimack ER, Appleman L, Fong L, Albiges L, Cohen L, Young TC, Chasalow SD, Ross-Macdonald P, Srivastava S, Jure-Kunkel M, Kurland JF, Simon JS, Sznol M.

Clin Cancer Res. 2016 Nov 15;22(22):5461-5471. doi: 10.1158/1078-0432.CCR-15-2839. Epub 2016 May 11.

33.

Treatment-related neuroendocrine prostate cancer resulting in Cushing's syndrome.

Ramalingam S, Eisenberg A, Foo WC, Freedman J, Armstrong AJ, Moss LG, Harrison MR.

Int J Urol. 2016 Dec;23(12):1038-1041. doi: 10.1111/iju.13225. Epub 2016 Oct 21.

34.

Resistance exercise training in patients with genitourinary cancers to mitigate treatment-related skeletal muscle loss.

Glass OK, Ramalingam S, Harrison MR.

Clin Adv Hematol Oncol. 2016 Jun;14(6):436-46. Review.

PMID:
27379813
35.

High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis.

Gopalakrishna A, Longo TA, Fantony JJ, Doshi U, Harrison MR, Van Noord M, Inman BA.

Urol Oncol. 2016 Sep;34(9):407-14. doi: 10.1016/j.urolonc.2016.05.009. Epub 2016 Jun 4. Review.

36.

Recent advancements in understanding endogenous heart regeneration-insights from adult zebrafish and neonatal mice.

Rubin N, Harrison MR, Krainock M, Kim R, Lien CL.

Semin Cell Dev Biol. 2016 Oct;58:34-40. doi: 10.1016/j.semcdb.2016.04.011. Epub 2016 Apr 27. Review.

37.
38.

Development of a Novel c-MET-Based CTC Detection Platform.

Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ.

Mol Cancer Res. 2016 Jun;14(6):539-47. doi: 10.1158/1541-7786.MCR-16-0011. Epub 2016 Mar 7.

39.

Impedance sensing device for monitoring ulcer healing in human patients.

Liao A, Lin MC, Ritz LC, Swisher SL, Ni D, Mann K, Khan Y, Roy S, Harrison MR, Arias AC, Subramanian V, Young D, Maharbiz MM.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:5130-3. doi: 10.1109/EMBC.2015.7319546.

PMID:
26737446
40.

MyPectus: First-in-human pilot study of remote compliance monitoring of teens using dynamic compression bracing to correct pectus carinatum.

Harrison B, Stern L, Chung P, Etemadi M, Kwiat D, Roy S, Harrison MR, Martinez-Ferro M.

J Pediatr Surg. 2016 Apr;51(4):608-11. doi: 10.1016/j.jpedsurg.2015.11.007. Epub 2015 Dec 1.

PMID:
26700692
41.

What Should We Tell Patients About Physical Activity After a Prostate Cancer Diagnosis?

Ramalingam S, Pollak KI, Zullig LL, Harrison MR.

Oncology (Williston Park). 2015 Sep;29(9):680-5, 687-8, 694. Review.

42.

Clinical Trial Participants With Metastatic Renal Cell Carcinoma Differ From Patients Treated in Real-World Practice.

Mitchell AP, Harrison MR, Walker MS, George DJ, Abernethy AP, Hirsch BR.

J Oncol Pract. 2015 Nov;11(6):491-7. doi: 10.1200/JOP.2015.004929. Epub 2015 Sep 1.

PMID:
26330533
43.

Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish.

Harrison MR, Bussmann J, Huang Y, Zhao L, Osorio A, Burns CG, Burns CE, Sucov HM, Siekmann AF, Lien CL.

Dev Cell. 2015 May 26;33(4):442-54. doi: 10.1016/j.devcel.2015.04.001.

44.

Optimizing the efficiency and quality of sipuleucel-T delivery in an academic institution.

Davis K, Wood S, Dill E, Fesko Y, Bitting RL, Harrison MR, Armstrong AJ, Moul JW, George DJ.

Clin J Oncol Nurs. 2015 Jun;19(3):297-303. doi: 10.1188/15.CJON.297-303.

PMID:
26000580
45.

Challenges and climate of business environment and resources to support pediatric device development.

Iqbal CW, Wall J, Harrison MR.

Semin Pediatr Surg. 2015 Jun;24(3):107-11. doi: 10.1053/j.sempedsurg.2015.02.006. Epub 2015 Mar 2.

PMID:
25976144
46.

Direct measurements show decreasing methane emissions from natural gas local distribution systems in the United States.

Lamb BK, Edburg SL, Ferrara TW, Howard T, Harrison MR, Kolb CE, Townsend-Small A, Dyck W, Possolo A, Whetstone JR.

Environ Sci Technol. 2015 Apr 21;49(8):5161-9. doi: 10.1021/es505116p. Epub 2015 Mar 31.

47.

Impedance sensing device enables early detection of pressure ulcers in vivo.

Swisher SL, Lin MC, Liao A, Leeflang EJ, Khan Y, Pavinatto FJ, Mann K, Naujokas A, Young D, Roy S, Harrison MR, Arias AC, Subramanian V, Maharbiz MM.

Nat Commun. 2015 Mar 17;6:6575. doi: 10.1038/ncomms7575.

PMID:
25779688
48.

Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer.

Stover JT, Moore RA, Davis K, Harrison MR, Armstrong AJ.

Prostate Cancer Prostatic Dis. 2015 Jun;18(2):161-6. doi: 10.1038/pcan.2015.7. Epub 2015 Mar 17.

PMID:
25777155
49.

Deferred systemic therapy in patients with metastatic renal cell carcinoma.

Mitchell AP, Hirsch BR, Harrison MR, Abernethy AP, George DJ.

Clin Genitourin Cancer. 2015 Jun;13(3):e159-66. doi: 10.1016/j.clgc.2014.12.017. Epub 2014 Dec 31.

PMID:
25770767
50.

Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.

Zhang T, Dhawan MS, Healy P, George DJ, Harrison MR, Oldan J, Chin B, Armstrong AJ.

Clin Genitourin Cancer. 2015 Aug;13(4):392-399. doi: 10.1016/j.clgc.2015.01.004. Epub 2015 Jan 24.

PMID:
25708161

Supplemental Content

Loading ...
Support Center